Drugs / Crocin
Crocin
also known as
.alpha.-crocin · Crocetin di(beta-gentiobiosyl)ester · Crocetin di-gentiobiose ester · Crocin 1
Trials 4 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT04936490 | Jul → Nov 2021 | central serous chorioretinopathy | Shiraz University of Medical Sciences | Unknown | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT03375814 | Jul 2016 → Mar 2018 | osteoarthritis, knee | Mashhad University of Medical Sciences | Unknown | No outcome recorded |
| Phase not applicable2 trials | ||||||
| — | NCT05696665 | Jul 2022 → Jul 2023 | Parkinson disease, neurodegenerative disease | Jinnah Postgraduate Medical Centre | Unknown | No outcome recorded |
| — | NCT05504148 | Mar 2021 → Jun 2023 | breast cancer | Qilu Hospital of Shandong University | Unknown | No outcome recorded |
Evidence & citations 8 cited values
Every value below carries the sentence it was read from. 6 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Crocin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03375814 ↗ |
| Known as | .alpha.-crocin | ChEMBL registry synonym — accepted as the source's own label CHEMBL446785 ↗ |
| Known as | Crocetin di(beta-gentiobiosyl)ester | ChEMBL registry synonym — accepted as the source's own label CHEMBL446785 ↗ |
| Known as | Crocetin di-gentiobiose ester | ChEMBL registry synonym — accepted as the source's own label CHEMBL446785 ↗ |
| Known as | Crocin 1 | ChEMBL registry synonym — accepted as the source's own label CHEMBL446785 ↗ |
| Action | Inhibit | “These results support that Crocin is a effective inhibitor of E46K α-synuclein fibrillization and it could be considered as a potential therapeutic agent in the treatment of...” PMID 31111370 ↗ May 2019 |
| Modality | Small molecule | “Crocin is a carotenoid chemical compound of saffron that has been shown antioxidant and neural protective activity.” PMID 31111370 ↗ May 2019 |
| Route | Oral | “Crocina tablets will be prescribed to the first group a tablet 15 mg daily along with conventional Medicines;” NCT03375814 ↗ |